{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:01:24Z","timestamp":1793797284030,"version":"4.6.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100020896","name":"Zayed Bin Sultan Center for Health Sciences, United Arab Emirates University","doi-asserted-by":"publisher","award":["12R168"],"award-info":[{"award-number":["12R168"]}],"id":[{"id":"10.13039\/501100020896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Epidemiol Glob Health"],"DOI":"10.1007\/s44197-025-00353-6","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T09:11:25Z","timestamp":1739178685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":144,"title":["Epidemiology of Multiple Sclerosis: Global, Regional, National and Sub-National-Level Estimates and Future Projections"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6836-1783","authenticated-orcid":false,"given":"Gulfaraz","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jawad","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"353_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41582-023-00838-7","volume":"19","author":"R Magliozzi","year":"2023","unstructured":"Magliozzi R, Howell OW, Calabrese M, Reynolds R. Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis. Nat Rev Neurol. 2023;19:461\u201376. https:\/\/doi.org\/10.1038\/s41582-023-00838-7.","journal-title":"Nat Rev Neurol"},{"key":"353_CR2","doi-asserted-by":"publisher","unstructured":"Peruzzotti-Jametti L, Willis CM, Krzak G, Hamel R, Pirvan L, Ionescu R-B et al. Mitochondrial complex I activity in microglia sustains neuroinflammation. Nature 2024:1\u20139. https:\/\/doi.org\/10.1038\/s41586-024-07167-9","DOI":"10.1038\/s41586-024-07167-9"},{"key":"353_CR3","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.1038\/s41467-023-42570-2","volume":"14","author":"J Groh","year":"2023","unstructured":"Groh J, Abdelwahab T, Kattimani Y, H\u00f6rner M, Loserth S, Gudi V, et al. Microglia-mediated demyelination protects against CD8\u2009+\u2009T cell-driven axon degeneration in mice carrying PLP defects. Nat Commun. 2023;14:6911. https:\/\/doi.org\/10.1038\/s41467-023-42570-2.","journal-title":"Nat Commun"},{"key":"353_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","volume":"378","author":"DS Reich","year":"2018","unstructured":"Reich DS, Lucchinetti CF, Calabresi PA, Multiple Sclerosis. N Engl J Med. 2018;378:169\u201380. https:\/\/doi.org\/10.1056\/NEJMra1401483.","journal-title":"N Engl J Med"},{"key":"353_CR5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.7861\/clinmed.2020-0292","volume":"20","author":"H Ford","year":"2020","unstructured":"Ford H. Clinical presentation and diagnosis of multiple sclerosis. Clin Med. 2020;20:380\u20133. https:\/\/doi.org\/10.7861\/clinmed.2020-0292.","journal-title":"Clin Med"},{"key":"353_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1474-4422(14)70267-4","volume":"14","author":"L Belbasis","year":"2015","unstructured":"Belbasis L, Bellou V, Evangelou E, Ioannidis JPA, Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol. 2015;14:263\u201373. https:\/\/doi.org\/10.1016\/S1474-4422(14)70267-4.","journal-title":"Lancet Neurol"},{"key":"353_CR7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S1474-4422(10)70094-6","volume":"9","author":"SV Ramagopalan","year":"2010","unstructured":"Ramagopalan SV, Dobson R, Meier UC, Giovannoni G. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol. 2010;9:727\u201339. https:\/\/doi.org\/10.1016\/S1474-4422(10)70094-6.","journal-title":"Lancet Neurol"},{"key":"353_CR8","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","volume":"286","author":"A Ascherio","year":"2001","unstructured":"Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hern\u00e1n MA, Olek MJ, et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA. 2001;286:3083\u20138.","journal-title":"JAMA"},{"key":"353_CR9","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1001\/jama.293.20.2496","volume":"293","author":"LI Levin","year":"2005","unstructured":"Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, et al. Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA. 2005;293:2496\u2013500. https:\/\/doi.org\/10.1001\/jama.293.20.2496.","journal-title":"JAMA"},{"key":"353_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375:296\u2013301. https:\/\/doi.org\/10.1126\/science.abj8222.","journal-title":"Science"},{"key":"353_CR11","doi-asserted-by":"publisher","unstructured":"Giovannoni G, Vanderdonckt P, Hartung H-P, Lassmann H, Comi G. EBV and multiple sclerosis: setting the research agenda. Mult Scler Relat Disord. 2022;67. https:\/\/doi.org\/10.1016\/j.msard.2022.104158.","DOI":"10.1016\/j.msard.2022.104158"},{"key":"353_CR12","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","volume":"296","author":"KL Munger","year":"2006","unstructured":"Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-Hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296:2832\u20138. https:\/\/doi.org\/10.1001\/jama.296.23.2832.","journal-title":"JAMA"},{"key":"353_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40120-017-0086-4","volume":"7","author":"MB Sintzel","year":"2017","unstructured":"Sintzel MB, Rametta M, Reder AT. Vitamin D and multiple sclerosis: a Comprehensive Review. Neurol Ther. 2017;7:59\u201385. https:\/\/doi.org\/10.1007\/s40120-017-0086-4.","journal-title":"Neurol Ther"},{"key":"353_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ana.22043","volume":"68","author":"S Simpson","year":"2010","unstructured":"Simpson S, Taylor B, Blizzard L, Ponsonby A-L, Pittas F, Tremlett H, et al. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol. 2010;68:193\u2013203. https:\/\/doi.org\/10.1002\/ana.22043.","journal-title":"Ann Neurol"},{"key":"353_CR15","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1038\/s41591-022-01990-1","volume":"28","author":"CJL Murray","year":"2022","unstructured":"Murray CJL. The global burden of Disease Study at 30 years. Nat Med. 2022;28:2019\u201326. https:\/\/doi.org\/10.1038\/s41591-022-01990-1.","journal-title":"Nat Med"},{"key":"353_CR16","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/S0140-6736(24)00812-2","volume":"403","author":"ZJ Ward","year":"2024","unstructured":"Ward ZJ, Goldie SJ. Global burden of Disease Study 2021 estimates: implications for health policy and research. Lancet. 2024;403:1958\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(24)00812-2.","journal-title":"Lancet"},{"key":"353_CR17","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1212\/wnl.53.8.1711","volume":"53","author":"MA Hern\u00e1n","year":"1999","unstructured":"Hern\u00e1n MA, Olek MJ, Ascherio A. Geographic variation of MS incidence in two prospective studies of US women. Neurology. 1999;53:1711\u20138. https:\/\/doi.org\/10.1212\/wnl.53.8.1711.","journal-title":"Neurology"},{"key":"353_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12883-015-0394-1","volume":"15","author":"GA Jelinek","year":"2015","unstructured":"Jelinek GA, Marck CH, Weiland TJ, Pereira N, van der Meer DM, Hadgkiss EJ. Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis. BMC Neurol. 2015;15:132. https:\/\/doi.org\/10.1186\/s12883-015-0394-1.","journal-title":"BMC Neurol"},{"key":"353_CR19","doi-asserted-by":"publisher","first-page":"e1191","DOI":"10.1212\/WNL.0000000000005257","volume":"90","author":"H Tremlett","year":"2018","unstructured":"Tremlett H, Zhu F, Ascherio A, Munger KL. Sun exposure over the life course and associations with multiple sclerosis. Neurology. 2018;90:e1191\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000005257.","journal-title":"Neurology"},{"key":"353_CR20","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1212\/WNL.28.11.1089","volume":"28","author":"M Alter","year":"1978","unstructured":"Alter M, Kahana E, Loewenson R. Migration and risk of multiple sclerosis. Neurology. 1978;28:1089\u20131089. https:\/\/doi.org\/10.1212\/WNL.28.11.1089.","journal-title":"Neurology"},{"key":"353_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","volume":"18","author":"MT Wallin","year":"2019","unstructured":"Wallin MT, Culpepper WJ, Nichols E, Bhutta ZA, Gebrehiwot TT, Hay SI, et al. Global, regional, and national burden of multiple sclerosis 1990\u20132016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol. 2019;18:269\u201385. https:\/\/doi.org\/10.1016\/S1474-4422(18)30443-5.","journal-title":"Lancet Neurol"},{"key":"353_CR22","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et al. Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler. 2020;26:1816\u201321. https:\/\/doi.org\/10.1177\/1352458520970841.","journal-title":"Mult Scler"},{"key":"353_CR23","doi-asserted-by":"publisher","unstructured":"Hittle M, Culpepper WJ, Langer-Gould A, Marrie RA, Cutter GR, Kaye WE, et al. Population-based estimates for the prevalence of multiple sclerosis in the United States by Race, Ethnicity, Age, Sex, and Geographic Region. JAMA Neurol. 2023;e231135. https:\/\/doi.org\/10.1001\/jamaneurol.2023.1135.","DOI":"10.1001\/jamaneurol.2023.1135"},{"key":"353_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2174\/187152712801661266","volume":"11","author":"G Disanto","year":"2012","unstructured":"Disanto G, Morahan M, Ramagopalan JV. Multiple sclerosis: risk factors and their interactions. CNS neurol disord - drug Targets- CNS. Neurol Disord. 2012;11:545\u201355. https:\/\/doi.org\/10.2174\/187152712801661266.","journal-title":"Neurol Disord"},{"key":"353_CR25","first-page":"1","volume":"19","author":"N Ghasemi","year":"2017","unstructured":"Ghasemi N, Razavi S, Nikzad E. Multiple sclerosis: Pathogenesis, symptoms, diagnoses and Cell-based therapy. Cell J Yakhteh. 2017;19:1\u201310.","journal-title":"Cell J Yakhteh"},{"key":"353_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.31083\/j.jin.2021.01.392","volume":"20","author":"C Br\u00fctting","year":"2021","unstructured":"Br\u00fctting C, Stangl GI, Staege MS, Vitamin D. Epstein-Barr virus, and endogenous retroviruses in multiple sclerosis - facts and hypotheses. J Integr Neurosci. 2021;20:233\u20138. https:\/\/doi.org\/10.31083\/j.jin.2021.01.392.","journal-title":"J Integr Neurosci"},{"key":"353_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","volume":"21","author":"SS Soldan","year":"2023","unstructured":"Soldan SS, Lieberman PM. Epstein\u2013Barr virus and multiple sclerosis. Nat Rev Microbiol. 2023;21:51\u201364. https:\/\/doi.org\/10.1038\/s41579-022-00770-5.","journal-title":"Nat Rev Microbiol"},{"key":"353_CR28","doi-asserted-by":"publisher","first-page":"e0167556","DOI":"10.1371\/journal.pone.0167556","volume":"11","author":"D Pivot","year":"2016","unstructured":"Pivot D, Debouverie M, Grzebyk M, Brassat D, Clanet M, Clavelou P, et al. Geographical heterogeneity of multiple sclerosis prevalence in France. PLoS ONE. 2016;11:e0167556. https:\/\/doi.org\/10.1371\/journal.pone.0167556.","journal-title":"PLoS ONE"},{"key":"353_CR29","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/1352458515594040","volume":"22","author":"I van der Mei","year":"2016","unstructured":"van der Mei I, Lucas RM, Taylor BV, Valery PC, Dwyer T, Kilpatrick TJ, et al. Population attributable fractions and joint effects of key risk factors for multiple sclerosis. Mult Scler Houndmills Basingstoke Engl. 2016;22:461\u20139. https:\/\/doi.org\/10.1177\/1352458515594040.","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"353_CR30","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1177\/1352458520907901","volume":"26","author":"BM Jacobs","year":"2020","unstructured":"Jacobs BM, Giovannoni G, Cuzick J, Dobson R. Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors. Mult Scler Houndmills Basingstoke Engl. 2020;26:1281\u201397. https:\/\/doi.org\/10.1177\/1352458520907901.","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"353_CR31","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1212\/WNL.0000000000002469","volume":"86","author":"P Dilokthornsakul","year":"2016","unstructured":"Dilokthornsakul P, Valuck RJ, Nair KV, Corboy JR, Allen RR, Campbell JD. Multiple sclerosis prevalence in the United States commercially insured population. Neurology. 2016;86:1014\u201321. https:\/\/doi.org\/10.1212\/WNL.0000000000002469.","journal-title":"Neurology"},{"key":"353_CR32","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1136\/jnnp.2011.240432","volume":"82","author":"S Simpson","year":"2011","unstructured":"Simpson S, Blizzard L, Otahal P, der Mei IV, Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82:1132\u201341. https:\/\/doi.org\/10.1136\/jnnp.2011.240432.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"353_CR33","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/brain\/awp033","volume":"132","author":"J Correale","year":"2009","unstructured":"Correale J, Ysrraelit MC, Gait\u00e1n MI. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain. 2009;132:1146\u201360. https:\/\/doi.org\/10.1093\/brain\/awp033.","journal-title":"Brain"},{"key":"353_CR34","doi-asserted-by":"publisher","first-page":"e1001866","DOI":"10.1371\/journal.pmed.1001866","volume":"12","author":"LE Mokry","year":"2015","unstructured":"Mokry LE, Ross S, Ahmad OS, Forgetta V, Smith GD, Leong A, et al. Vitamin D and risk of multiple sclerosis: a mendelian randomization study. PLOS Med. 2015;12:e1001866. https:\/\/doi.org\/10.1371\/journal.pmed.1001866.","journal-title":"PLOS Med"},{"key":"353_CR35","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1212\/NXG.0000000000000097","volume":"2","author":"B Rhead","year":"2016","unstructured":"Rhead B, B\u00e4\u00e4rnhielm M, Gianfrancesco M, Mok A, Shao X, Quach H, et al. Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk. Neurol Genet. 2016;2:e97. https:\/\/doi.org\/10.1212\/NXG.0000000000000097.","journal-title":"Neurol Genet"},{"key":"353_CR36","doi-asserted-by":"publisher","unstructured":"Jelinek GA. Determining causation from Observational studies: a challenge for modern neuroepidemiology. Front Neurol. 2017;8. https:\/\/doi.org\/10.3389\/fneur.2017.00265.","DOI":"10.3389\/fneur.2017.00265"},{"key":"353_CR37","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1212\/WNL.0000000000003849","volume":"88","author":"MA Gianfrancesco","year":"2017","unstructured":"Gianfrancesco MA, Stridh P, Rhead B, Shao X, Xu E, Graves JS, et al. Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. Neurology. 2017;88:1623\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000003849.","journal-title":"Neurology"},{"key":"353_CR38","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.cell.2023.03.008","volume":"186","author":"M Charabati","year":"2023","unstructured":"Charabati M, Wheeler MA, Weiner HL, Quintana FJ. Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting. Cell. 2023;186:1309\u201327. https:\/\/doi.org\/10.1016\/j.cell.2023.03.008.","journal-title":"Cell"},{"key":"353_CR39","doi-asserted-by":"publisher","first-page":"1503808","DOI":"10.3389\/fimmu.2024.1503808","volume":"15","author":"A Rasheed","year":"2024","unstructured":"Rasheed A, Khan G. Epstein-Barr virus, vitamin D and the immune response: connections with consequences for multiple sclerosis. Front Immunol. 2024;15:1503808. https:\/\/doi.org\/10.3389\/fimmu.2024.1503808.","journal-title":"Front Immunol"},{"key":"353_CR40","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/ana.20820","volume":"59","author":"EL Thacker","year":"2006","unstructured":"Thacker EL, Mirzaei F, Ascherio A. Infectious Mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol. 2006;59:499\u2013503. https:\/\/doi.org\/10.1002\/ana.20820.","journal-title":"Ann Neurol"},{"key":"353_CR41","doi-asserted-by":"publisher","first-page":"e0192109","DOI":"10.1371\/journal.pone.0192109","volume":"13","author":"A Hassani","year":"2018","unstructured":"Hassani A, Corboy JR, Al-Salam S, Khan G. Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just b cells. PLoS ONE. 2018;13:e0192109. https:\/\/doi.org\/10.1371\/journal.pone.0192109.","journal-title":"PLoS ONE"},{"key":"353_CR42","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1084\/jem.20071030","volume":"204","author":"B Serafini","year":"2007","unstructured":"Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P, et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med. 2007;204:2899\u2013912. https:\/\/doi.org\/10.1084\/jem.20071030.","journal-title":"J Exp Med"},{"key":"353_CR43","doi-asserted-by":"publisher","first-page":"e466","DOI":"10.1212\/NXI.0000000000000466","volume":"5","author":"MA Moreno","year":"2018","unstructured":"Moreno MA, Or-Geva N, Aftab BT, Khanna R, Croze E, Steinman L, et al. Molecular signature of Epstein-Barr virus infection in MS brain lesions. Neurol Neuroimmunol Neuroinflammation. 2018;5:e466. https:\/\/doi.org\/10.1212\/NXI.0000000000000466.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"353_CR44","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","volume":"603","author":"TV Lanz","year":"2022","unstructured":"Lanz TV, Brewer RC, Ho PP, Moon J-S, Jude KM, Fernandez D, et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature. 2022;603:321\u20137. https:\/\/doi.org\/10.1038\/s41586-022-04432-7.","journal-title":"Nature"},{"key":"353_CR45","doi-asserted-by":"publisher","first-page":"eadg3032","DOI":"10.1126\/sciadv.adg3032","volume":"9","author":"OG Thomas","year":"2023","unstructured":"Thomas OG, Bronge M, Tengvall K, Akpinar B, Nilsson OB, Holmgren E, et al. Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis. Sci Adv. 2023;9:eadg3032. https:\/\/doi.org\/10.1126\/sciadv.adg3032.","journal-title":"Sci Adv"},{"key":"353_CR46","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1474-4422(22)00471-9","volume":"22","author":"F Aloisi","year":"2023","unstructured":"Aloisi F, Giovannoni G, Salvetti M. Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy. Lancet Neurol. 2023;22:338\u201349. https:\/\/doi.org\/10.1016\/S1474-4422(22)00471-9.","journal-title":"Lancet Neurol"},{"key":"353_CR47","doi-asserted-by":"publisher","first-page":"eaax1729","DOI":"10.1126\/scitranslmed.aax1729","volume":"11","author":"M Boyle","year":"2019","unstructured":"Boyle M. A vaccine to kiss EBV goodbye. Sci Transl Med. 2019;11:eaax1729. https:\/\/doi.org\/10.1126\/scitranslmed.aax1729.","journal-title":"Sci Transl Med"},{"key":"353_CR48","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1172\/JCI128370","volume":"129","author":"S Sharma","year":"2019","unstructured":"Sharma S, Rouce RH. Are we there yet? The never-ending quest for an Epstein-Barr virus vaccine. J Clin Invest. 2019;129:1836\u20138. https:\/\/doi.org\/10.1172\/JCI128370.","journal-title":"J Clin Invest"},{"key":"353_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf3685","author":"C-J Wei","year":"2022","unstructured":"Wei C-J, Bu W, Nguyen LA, Batchelor JD, Kim J, Pittaluga S, et al. A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice. Sci Transl Med. 2022. https:\/\/doi.org\/10.1126\/scitranslmed.abf3685.","journal-title":"Sci Transl Med"},{"key":"353_CR50","doi-asserted-by":"publisher","first-page":"e037505","DOI":"10.1136\/bmjopen-2020-037505","volume":"10","author":"G Khan","year":"2020","unstructured":"Khan G, Fitzmaurice C, Naghavi M, Ahmed LA. Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990\u20132017. BMJ Open. 2020;10:e037505. https:\/\/doi.org\/10.1136\/bmjopen-2020-037505.","journal-title":"BMJ Open"},{"key":"353_CR51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","volume":"148","author":"Y Wong","year":"2022","unstructured":"Wong Y, Meehan MT, Burrows SR, Doolan DL, Miles JJ. Estimating the global burden of Epstein-Barr virus-related cancers. J Cancer Res Clin Oncol. 2022;148:31\u201346. https:\/\/doi.org\/10.1007\/s00432-021-03824-y.","journal-title":"J Cancer Res Clin Oncol"},{"key":"353_CR52","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/1352458518807082","volume":"25","author":"P Soelberg Sorensen","year":"2019","unstructured":"Soelberg Sorensen P, Giovannoni G, Montalban X, Thalheim C, Zaratin P, Comi G. The multiple sclerosis care unit. Mult Scler J. 2019;25:627\u201336. https:\/\/doi.org\/10.1177\/1352458518807082.","journal-title":"Mult Scler J"},{"key":"353_CR53","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1071\/HC16006","volume":"8","author":"MJ Hashim","year":"2016","unstructured":"Hashim MJ. Principles of family medicine and general practice - defining the five core values of the specialty. J Prim Health Care. 2016;8:283\u20137. https:\/\/doi.org\/10.1071\/HC16006.","journal-title":"J Prim Health Care"},{"key":"353_CR54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1474-4422(22)00040-0","volume":"21","author":"BAC Cree","year":"2022","unstructured":"Cree BAC, Oksenberg JR, Hauser SL. Multiple sclerosis: two decades of progress. Lancet Neurol. 2022;21:211\u20134. https:\/\/doi.org\/10.1016\/S1474-4422(22)00040-0.","journal-title":"Lancet Neurol"},{"key":"353_CR55","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/13524585221075990","volume":"28","author":"BF Bebo","year":"2022","unstructured":"Bebo BF, Allegretta M, Landsman D, Zackowski KM, Brabazon F, Kostich WA, et al. Pathways to cures for multiple sclerosis: a research roadmap. Mult Scler J. 2022;28:331\u201345. https:\/\/doi.org\/10.1177\/13524585221075990.","journal-title":"Mult Scler J"},{"key":"353_CR56","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1212\/WNL.0000000000007837","volume":"93","author":"FJ Mateen","year":"2019","unstructured":"Mateen FJ. Multiple sclerosis in resource-limited settings. Neurology. 2019;93:176\u201380. https:\/\/doi.org\/10.1212\/WNL.0000000000007837.","journal-title":"Neurology"},{"key":"353_CR57","doi-asserted-by":"publisher","first-page":"76","DOI":"10.29271\/jcpsp.2018.01.76","volume":"28","author":"MJ Hashim","year":"2018","unstructured":"Hashim MJ. A definition of Family Medicine and General Practice. J Coll Physicians Surg\u2013Pak JCPSP. 2018;28:76\u20137. https:\/\/doi.org\/10.29271\/jcpsp.2018.01.76.","journal-title":"J Coll Physicians Surg\u2013Pak JCPSP"},{"key":"353_CR58","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1177\/1352458510379614","volume":"16","author":"BV Taylor","year":"2010","unstructured":"Taylor BV, Pearson JF, Clarke G, Mason DF, Abernethy DA, Willoughby E, et al. MS prevalence in New Zealand, an ethnically and latitudinally diverse country. Mult Scler Houndmills Basingstoke Engl. 2010;16:1422\u201331. https:\/\/doi.org\/10.1177\/1352458510379614.","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"353_CR59","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.msard.2013.06.015","volume":"3","author":"N Makhani","year":"2014","unstructured":"Makhani N, Morrow SA, Fisk J, Evans C, Beland SG, Kulaga S, et al. MS incidence and prevalence in Africa, Asia, Australia and New Zealand: a systematic review. Mult Scler Relat Disord. 2014;3:48\u201360. https:\/\/doi.org\/10.1016\/j.msard.2013.06.015.","journal-title":"Mult Scler Relat Disord"},{"key":"353_CR60","unstructured":"Atlas of MS n.d. https:\/\/www.atlasofms.org\/map\/global\/epidemiology\/number-of-people-with-ms (accessed January 14, 2025)."}],"container-title":["Journal of Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-025-00353-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44197-025-00353-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-025-00353-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T09:11:29Z","timestamp":1739178689000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44197-025-00353-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["353"],"URL":"https:\/\/doi.org\/10.1007\/s44197-025-00353-6","relation":{},"ISSN":["2210-6014"],"issn-type":[{"value":"2210-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. Publicly available data was used for the analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"No artificial intelligence tools were employed. All analyses and interpretations were conducted manually by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Artificial Intelligence"}},{"value":"All authors confirm that they had full access to all the data in the study and accept responsibility to submit for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"21"}}